Original ArticlePancreas, Biliary Tract, and LiverDifferences in Age at Onset of Symptoms, and Effects of Genetic Variants, in Patients With Early vs Late-Onset Idiopathic Chronic Pancreatitis in a North American Cohort
Section snippets
North American Pancreatitis Studies
NAPS2 is a set of 3 studies (the original NAPS2 study, NAPS2 continuation and validation study, and NAPS2 Ancillary Study) that prospectively enrolled 1195 patients with CP from 26 centers in the United States from August 2000 to December 2014.18, 19, 20 The diagnosis of CP was based on definitive changes on abdominal imaging studies, specifically endoscopic retrograde cholangiopancreatography, contrast-enhanced computed tomography, magnetic resonance imaging, endoscopic ultrasound, or
Study Cohort
The final sample size for this study was 663 patients with CP. Of these, 130 (19.6%) were lifetime alcohol abstainers placed in 1 of the 2 ICP groups, 308 (46.5%) were light to moderate alcohol drinkers with CP, and 225 (33.9%) were heavy to very heavy alcohol drinkers placed in the ACP group (Figure 1). Among the 130 patients with ICP, 61 (46.9%) had EO-ICP and 69 (53.1%) had LO-ICP.
Demographics, History of Smoking, and Age at Onset of Symptoms
The age at onset of pancreatitis symptoms and pancreatitis diagnosis in patients with ICP followed a bimodal
Discussion
The NAPS2 cohort allows for the reevaluation of prior descriptive studies of cohorts of CP in light of newer insights into etiopathogenesis, including genetics. We confirmed the existence of 2 types of ICP, EO-ICP and LO-ICP, with a nearly identical bimodal age distribution to the previously published series.7 We also confirmed several other clinical features that characterize patients with EO-ICP and LO-ICP, suggesting that they represent 2 distinct populations of patients with overlapping
Acknowledgments
Presented at Digestive Disease Week, Chicago, IL, May 5–9, 2017.
The authors acknowledge contributions from Kimberly Stello and Danielle Dwyer for laboratory management, Michael O’Connell, PhD, for the Epidemiology Data Center, and Lisa Kennard, PhD, Tian Ye, and Stephen R. Wisniewski, PhD, for data management.
Current affiliations of J.T.: Department of Medicine, A1A Hospitalists, Phoenix, Arizona; DLC: Department of Medicine, The Ohio State University, Columbus, Ohio; G.A.C.: Department of
References (24)
- et al.
The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis
Gastroenterology
(1994) - et al.
The effect of small amounts of alcohol on the clinical course of chronic pancreatitis
Mayo Clin Proc
(2001) - et al.
Risk of recurrent pancreatitis and progression to chronic pancreatitis after a first episode of acute pancreatitis
Clin Gastroenterol Hepatol
(2016) - et al.
Multicenter approach to recurrent acute and chronic pancreatitis in the United States: the North American Pancreatitis Study 2 (NAPS2)
Pancreatology
(2008) - et al.
Chronic pancreatitis pain pattern and severity are independent of abdominal imaging findings
Clin Gastroenterol Hepatol
(2015) - et al.
Known genetic susceptibility factors for chronic pancreatitis in patients of European ancestry are rare in patients of African ancestry
Pancreatology
(2018) - et al.
Combined bicarbonate conductance-impairing variants in CFTR and SPINK1 variants are associated with chronic pancreatitis in patients without cystic fibrosis
Gastroenterology
(2011) - et al.
Course and outcome of chronic pancreatitis. Longitudinal study of a mixed medical-surgical series of 245 patients
Gastroenterology
(1984) - et al.
Chronic pancreatitis in the Western Cape
Digestion
(1973) - et al.
A multicenter inquiry into the etiology of pancreatic diseases
Digestion
(1979)
Chronic pancreatitis
Ann Intern Med
Smoking and risk of acute and chronic pancreatitis among women and men: a population-based cohort study
Arch Intern Med
Cited by (14)
No Convincing Evidence to Support a Bimodal Age of Onset in Idiopathic Chronic Pancreatitis
2022, Clinical Gastroenterology and HepatologyHereditary pancreatitis in a young adult: Acute to chronic
2021, Clinical BiochemistryCitation Excerpt :In contrast, early onset CP is extremely rare, occurs at a median age of 20 years, and presents with intermittent attacks of acute pancreatitis (AP). About half of all early onset CP cases are associated with pathogenic variants in either the trypsin homeostasis pathway, also known as HP, or in the cystic fibrosis transmembrane conductance regulator (CFTR) gene [3,4]. For HP, these disease-causing variants include gain-of-function mutations in the cationic trypsinogen gene (PRSS1) or loss-of-function variants in the serine protease inhibitor Kazal-type 1 (SPINK1) and chymotrypsin C (CTRC) genes.
Issue Highlights
2021, Clinical Gastroenterology and Hepatology
Conflicts of interest This author discloses the following: David C. Whitcomb serves as a consultant for AbbVie, Regeneron, and Ariel Precision Medicine, and is a cofounder of Ariel Precision Medicine and may have equity. The remaining authors disclose no conflicts.
Funding This research was supported in part by National Institutes of Health grants DK061451 (D.C.W.), DK077906 (D.Y.), U01 DK108306 (D.C.W., D.Y.), and UO1DK108320 (C.E.F.). This publication was made possible in part by grants UL1 RR024153 and UL1TR000005 from the National Center for Research Resources, a component of the National Institutes of Health, and the National Institutes of Health Roadmap for Medical Research (University of Pittsburgh). The contents of this article are solely the responsibility of the authors and do not necessarily represent the official view of the National Center for Research Resources or the National Institutes of Health.
- a
Authors share co-senior authorship.